OpenNashEarnings

Consumer Brands · NYSE: MO

Altria earnings: results, call transcripts & KPI history

2 quarters · fiscal year ends December · next results expected around 28 Jan 2027

Investor relations ↗SEC filings ↗KPIs as CSV

Latest: Q3 2026

Altria expanded on! PLUS nationally with 12-milligram strength and new flavors while suing the FDA over slow authorization of new nicotine products.

Altria's pouch brand on! grew shipments 13.3% to 47.8 million cans as nicotine pouches passed 60% of the oral category. Helix rolled out on! PLUS 12-milligram nationally and added Blueberry Mint and Mango Pineapple, with Watermelon Mint next. In cigarettes, Marlboro Cowboy Cut gave price-sensitive smokers a premium option, lifting Marlboro's share of premium to 60.0%, while Basic gained share in discount.

Read the Q3 2026 summary →

Quarters

KPI history

Revenue$6.1B+1.0% y/yQ3 2026
Q4 2024: $6.0B (worked out from the annual figure)Q4 ’24$6.0BQ1 2025: $5.3BQ1 ’25$5.3BQ2 2025: $6.1BQ2 ’25$6.1BQ3 2025: $6.1BQ3 ’25$6.1BQ4 2025: $5.8B (worked out from the annual figure)Q4 ’25$5.8BQ1 2026: $5.4BQ1 ’26$5.4BQ2 2026: $6.1BQ2 ’26$6.1BQ3 2026: $6.1BQ3 ’26$6.1B

Fourth quarter worked out from the annual figure.

Data
Q4 2024$6.0B *
Q1 2025$5.3B
Q2 2025$6.1B
Q3 2025$6.1B
Q4 2025$5.8B *
Q1 2026$5.4B
Q2 2026$6.1B
Q3 2026$6.1B
Diluted EPS (GAAP)$1.51+7.1% y/yQ3 2026
Q1 2025: $0.63Q1 ’25$0.63Q2 2025: $1.41Q2 ’25$1.41Q3 2025: $1.41Q3 ’25$1.41Q1 2026: $1.30Q1 ’26$1.30Q2 2026: $1.37Q2 ’26$1.37Q3 2026: $1.51Q3 ’26$1.51
Data
Q1 2025$0.63
Q2 2025$1.41
Q3 2025$1.41
Q1 2026$1.30
Q2 2026$1.37
Q3 2026$1.51

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Operating margin54.0%+0.8 pts y/yQ3 2026
Q4 2024: 48.2%Q4 ’2448.2%Q1 2025: 34.0%Q1 ’2534.0%Q2 2025: 52.9%Q2 ’2552.9%Q3 2025: 53.2%Q3 ’2553.2%Q4 2025: 28.2%Q4 ’2528.2%Q1 2026: 54.5%Q1 ’2654.5%Q2 2026: 51.3%Q2 ’2651.3%Q3 2026: 54.0%Q3 ’2654.0%
Data
Q4 202448.2%
Q1 202534.0%
Q2 202552.9%
Q3 202553.2%
Q4 202528.2%
Q1 202654.5%
Q2 202651.3%
Q3 202654.0%
Free cash flow$3.0B−1.3% y/yQ3 2026
Q4 2024: $3.3BQ4 ’24$3.3BQ1 2025: $2.7BQ1 ’25$2.7BQ2 2025: $173.0MQ2 ’25$173.0MQ3 2025: $3.0BQ3 ’25$3.0BQ4 2025: $3.2BQ4 ’25$3.2BQ1 2026: $2.2BQ1 ’26$2.2BQ2 2026: $662.0MQ2 ’26$662.0MQ3 2026: $3.0BQ3 ’26$3.0B
Data
Q4 2024$3.3B
Q1 2025$2.7B
Q2 2025$173.0M
Q3 2025$3.0B
Q4 2025$3.2B
Q1 2026$2.2B
Q2 2026$662.0M
Q3 2026$3.0B

Operating cash flow minus capital expenditure, from cash flow statements.

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue$6.0Bd$5.3B$6.1B$6.1B$5.8Bd$5.4B$6.1B$6.1B
Gross margin60.3%61.8%63.1%62.8%62.1%64.6%62.5%64.3%
Operating income$2.9Bd$1.8B$3.2B$3.2B$1.7Bd$3.0B$3.1B$3.3B
Operating margin48.2%34.0%52.9%53.2%28.2%54.5%51.3%54.0%
Net income$3.0Bd$1.1B$2.4B$2.4B$1.1Bd$2.2B$2.3B$2.5B
Diluted EPS—$0.63$1.41$1.41—$1.30$1.37$1.51
Operating cash flow$3.3Bd$2.7B$205.0Md$3.1Bd$3.3Bd$2.3B$719.0Md$3.1Bd
Capital expenditure$47.0Md$38.0M$32.0Md$54.0Md$92.0Md$93.0M$57.0Md$109.0Md
Free cash flow$3.3B$2.7B$173.0M$3.0B$3.2B$2.2B$662.0M$3.0B

From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.

10-K and 10-Q filings